K index utility as diagnostic and prognostic biomarker in the assessment of patients with suspected Multiple Sclerosis
Journal of Neuroimmunology, ISSN: 0165-5728, Vol: 373, Page: 577992
2022
- 7Citations
- 8Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations7
- Citation Indexes7
- Captures8
- Readers8
Article Description
The aim of the present study is to evaluate the composite role of k index in the initial assessment of Multiple Sclerosis (MS) patients and to select useful cut-offs exportable in clinical practice. We analysed CSF/serum samples of 140 patients and followed-up the CIS/MS subgroup for 7 years. Our results suggest κ index as a quantitative diagnostic and prognostic biomarker in MS, significantly associated to baseline lesion load and to successive clinical course. We propose k index ≥106 as a prognostic cut-off to select patients at major risk of relapse, potentially influencing initial therapeutic decisions.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0165572822001874; http://dx.doi.org/10.1016/j.jneuroim.2022.577992; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85141280051&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/36335693; https://linkinghub.elsevier.com/retrieve/pii/S0165572822001874; https://dx.doi.org/10.1016/j.jneuroim.2022.577992
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know